Peripheral Treg-monocyte immune signatures relate to neurodegeneration and prognosis in patients with primary tauopathies
Lai, K. O.; Goddard, J.; Crook, H.; Frohn, R.; Kigar, S. L.; Yarkoni, N. S.; Swann, P.; Durcan, R.; Wiggins, J.; Li, W.; Paula, H.; Rittman, T.; Heslegrave, A.; Rowe, J.; Brendel, M.; Zetterberg, H.; Priller, J.; O'Brien, J. T.; Malpetti, M.
Show abstract
BackgroundNeuroinflammation is a common hallmark of primary tauopathies, and is associated with worse clinical outcomes over time. However, accurate prognosis in these disorders remains challenging, and current fluid biomarkers provide limited insight into the contribution of peripheral immune cells to PSP/CBS pathogenesis. Our study aims to characterise blood-based immune cell profiles in patients with progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), and test their associations with neurodegeneration and clinical outcomes. MethodsPeripheral blood immune cells from fresh whole blood were characterized with high-dimensional mass cytometry (29 markers) in n=60 people with PSP/CBS and n=21 age- and sex-matched controls. Cell type abundance was defined as the ratio of counts for each gated population divided by total live cells. Hierarchical clustering of cell types and principal component analysis were used to derive data-driven immune clusters. Correlation network analysis and diffusion-based network propagation integrated cell counts with plasma inflammation markers to prioritise mediators of intercellular signalling. Associations between immunological markers, plasma concentrations of neurofilament light chain (NfL), cognition, and survival were assessed using regression and Cox proportional hazards models. ResultsPatients with PSP/CBS showed a global increase in covariance among immune cell populations, indicating heightened coordination within the peripheral immune network. A monocyte-driven cluster (Cluster 1) showed higher scores in PSP/CBS, reflecting impaired phenotypic transition from classical to nonclassical monocytes, and was associated with higher NfL levels, poorer cognitive performance, and worse prognosis. In contrast, a Treg-driven cluster (Cluster 2) showed lower scores in PSP/CBS, and was associated with better cognition and longer survival. Integrated multimodal networks identified a small set of immune-regulatory molecules and cytokines mediating crosstalk between Treg/Th17-like cells and monocytic populations, supporting a dysregulated Treg-monocyte axis in PSP/CBS. ConclusionsWe identified peripheral blood-based immunophenotypic profiles of individuals with PSP/CBS that are associated with neurodegeneration, cognitive decline, and survival. Dysregulated monocyte maturation and reduced Treg-related immune configurations are enriched in patients with worse outcomes, suggesting that specific peripheral immune cell subsets may serve as fluid biomarkers and potential immunotherapy targets in primary tauopathies.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.